Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Broad Center for Mendelian Genomics, |
RCV001005020 | SCV001164585 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2018-12-03 | criteria provided, single submitter | research | The heterozygous c.951+3_951+4delAT variant in DYSF was identified by our study in the compound heterozygous state, with a VUS, in two siblings with limb-girdle muscular dystrophy (LGMD). This variant was absent from large population studies. This variant is located in the 5’ splice region. Computational tools do suggest an impact to splicing (destruction of a natural splice site and creation of an in-frame cryptic splice site) and another variant predicted to impact the same splicing site was reported pathogenic in ClinVar (Variation ID: 283267). However, this information is not predictive enough to determine pathogenicity. Loss of function of the DYSF gene is an established disease mechanism for autosomal recessive LGMD. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PVS1_Moderate, PP1 (Richards 2015). |
Ce |
RCV001726413 | SCV001962262 | likely pathogenic | not provided | 2021-08-01 | criteria provided, single submitter | clinical testing |